# US 2015/0377862 A1 · Method to evaluate the tissue targeting of a molecule of interest

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0377862 A1
- Document ID: US20150377862A1
- Status: Published application
- Kind: A1
- Application number: 14/769,550
- Filed: 2014-02-25
- Published: 2015-12-31
- Earliest claimed: 2013-02-25
- Assignees: Imabiotech
- Applicants: Imabiotech
- Inventors: GRÉGORY HAMM; JONATHAN STAUBER
- Web page: https://patentgrep.com/patent/US20150377862A1

## CPC

- G01N 33/5035: {on sub-cellular localization}
- A61K 49/0008: {Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure}
- G01N 33/5082: {Supracellular entities, e.g. tissue, organisms}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The invention relates to a method for evaluating if a molecule of interest binds or is incorporated in, at least one target tissue comprising visualizing and comparing the distribution of the molecule of interest and of at least one control compound within the target tissue or on the target tissue surface of at least one animal that has previously received the molecule of interest and/or the control compound. Advantageously, the distribution of the molecule of interest is visualized and compared with the distribution of positive and negative compounds using mass spectrometry imaging on the surface of the target tissue.

## Claims

### Claim at position 1

1-15. (canceled)

### Claim 16

A method for evaluating if a molecule of interest binds or is incorporated in at least one target tissue, comprising visualizing and comparing the distribution of the molecule of interest and of at least one control compound within the target tissue or on the target tissue surface of at least one animal that has previously received the molecule of interest and/or the control compound.

### Claim 17 (depends on 16)

The method for evaluating if a molecule of interest hinds or is incorporated in at least one target tissue according to claim 16, comprising visualizing and comparing the distribution of the molecule of interest and of at least one control compound on the surface of at least one target tissue section previously obtained by sampling in said animal.

### Claim 18 (depends on 16)

The method for evaluating if a molecule of interest binds or is incorporated in at least one target tissue according to claim 16, wherein a control positive compound and a control negative compound have been previously administered to the animal.

### Claim 19 (depends on 16)

The method for evaluating if a molecule of interest binds or is incorporated in at least one target tissue according to claim 16, wherein the molecule of interest and the control compound have been previously co-administered to the animal.

### Claim 20 (depends on 16)

The method for evaluating if a molecule of interest binds or is incorporated in at least one target tissue according to claim 16, wherein the same concentration of the control compound and molecule of interest have been previously administered to the animal.

### Claim 21 (depends on 16)

The method for evaluating if a molecule of interest binds or is incorporated in at least one target tissue according to claim 16, wherein the molecule of interest and/or control compound have been previously administered enterally or parenterally to the animal.

### Claim 22 (depends on 16)

The method for evaluating if a molecule of interest binds or is incorporated in at least one target tissue according to claim 16, wherein the visualization step of the distribution of the molecule of interest and control compound is achieved using imaging techniques.

### Claim 23 (depends on 22)

The method for evaluating if a molecule of interest binds or is incorporated in at least one target tissue according to claim 22, wherein the visualization step of the distribution of the molecule of interest and control compound is achieved using mass spectrometry molecular imaging.

### Claim 24 (depends on 22)

The method for evaluating if a molecule of interest binds or is incorporated in at least one target tissue according to claim 22, wherein signals related to mass spectra of the molecule of interest and/or control compound are normalized to take into account a tissue extinction coefficient (TEC) and/or biological matrix effect.

### Claim 25 (depends on 23)

The method for evaluating if a molecule of interest binds or is incorporated in at least one target tissue according to claim 23, wherein signals related to mass spectra of the molecule of interest and/or control compound are normalized to take into account a tissue extinction coefficient (TEC) and/or biological matrix effect.

### Claim 26 (depends on 16)

The method for evaluating if a molecule of interest binds or is incorporated in at least one target tissue according to claim 16, wherein the specificity of the molecule of interest for the target tissue is assessed by comparing the distribution of said molecule in the target tissue with the distribution of said molecule in at least one non-target tissue.

### Claim 27 (depends on 16)

The method for evaluating if a molecule of interest binds or is incorporated in at least one target tissue according to claim 16, wherein a penetration ratio of the molecule of interest for the target tissue is evaluated by comparing the distribution of said molecule within the target tissue with the distribution of the control compound within said target tissue.

### Claim 28 (depends on 16)

The method for evaluating if a molecule of interest binds or is incorporated in at least one target tissue according to claim 16, further comprising a step of evaluation of the kinetics of the molecule of interest that compares the distribution of said molecule into at least two target tissue sections previously obtained by sampling at different times (t1) and (t2) animals which were previously administered with the molecule of interest.

### Claim 29 (depends on 16)

The method for evaluating if a molecule of interest binds or is incorporated in at least one target tissue according to claim 16, wherein the molecule of interest is a candidate molecule, a therapeutic potential molecule or a phytosanitary potential molecule or one of its metabolites.

### Claim 30 (depends on 16)

The method for evaluating if a molecule of interest binds or is incorporated in at least one target tissue according to claim 16, wherein said animal or target tissue or tissue section is treated to modify its capacity to bind and/or incorporate the molecule of interest within the target tissue.

### Claim 31 (depends on 16)

A computer-readable data medium comprising computer-executable instructions suited to enable a computer system to execute the comparison of the distribution of the molecule of interest with the distribution of at least one control compound according to the method of claim 16.
